Glioblastoma. Malignant neoplasm of brain, unspecified
Conditions
Interventions
The intervention groups include glioblastoma patients whose mass has been proven by imaging methods such as MRI. This evaluation is a diagnostic method using the single photon emission computed tomogr
Sponsors
Shiraz University of Medical Sciences
Nuclear Science and Technology Research Institute
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient has been diagnosed with glioma based on MRI within the last month The patient is a candidate for surgical resection and has not undergone any type of anti-cancer treatment The patient's condition is stable for the scan The patient consents to the scan, and at the time of the scan Do not be pregnant or breastfeeding
Exclusion criteria
Exclusion criteria: Patients with multiple masses Patients who need emergency interventions after initial diagnosis Patients whose tumor cannot be operated Patients who do not consent to scan or surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The mean amount of radioactivity uptake in low-grade glioma patients. Timepoint: 3 hours after radiopharmaceutical administration. Method of measurement: SPECT/CT imaging.;The mean amount of radioactivity uptake in high-grade glioma patients. Timepoint: 3 hours after radiopharmaceutical administration. Method of measurement: SPECT/CT imaging.;Sensitivity of imaging to detect high-grade glioma. Timepoint: 3 hours after radiopharmaceutical administration. Method of measurement: SPECT/CT imaging and comparison with pathology results.;Sensitivity of imaging to detect low-grade glioma. Timepoint: 3 hours after radiopharmaceutical administration. Method of measurement: SPECT/CT imaging and comparison with pathology results. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. tahereh firuzyar
Shiraz University of Medical Sciences
Outcome results
None listed